779 related articles for article (PubMed ID: 27002950)
1. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.
Liao M; Huang J; Zhang T; Wu H
PLoS One; 2013; 8(7):e68453. PubMed ID: 23844203
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Cao JH; Zhou J; Zhang XL; Ding X; Long QY
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
[TBL] [Abstract][Full Text] [Related]
10. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
Wang X; Hu Y; Ren M; Lu X; Lu G; He S
Korean J Radiol; 2016; 17(1):93-102. PubMed ID: 26798221
[TBL] [Abstract][Full Text] [Related]
12. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
13. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
Lan T; Chang L; Mn R; Wu L; Yuan YF
Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
[TBL] [Abstract][Full Text] [Related]
14. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis.
Liu Z; Gao F; Yang G; Singh S; Lu M; Zhang T; Zhong Z; Zhang F; Tang R
Tumour Biol; 2014 Aug; 35(8):7407-13. PubMed ID: 24777334
[TBL] [Abstract][Full Text] [Related]
15. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
16. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
[TBL] [Abstract][Full Text] [Related]
18. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center.
Bharadwaz A; Bak-Fredslund KP; Villadsen GE; Nielsen JE; Simonsen K; Sandahl TD; Grønbæk H; Nielsen DT
Acta Radiol; 2016 Jul; 57(7):844-51. PubMed ID: 26342009
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
20. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison.
Zhao J; Zhang H; Wei L; Xie S; Suo Z
Oncotarget; 2017 Feb; 8(9):15101-15113. PubMed ID: 27835871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
